Niagen Bioscience to Present at LD Micro 20th Annual Main Event

LOS ANGELES–(BUSINESS WIRE)—- $NAGE #Biotech–Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the 20th Annual LD Micro Main Event from Monday, October 19 to 21, 2026, in Los Angeles, CA. Niagen Bioscience Chief Executive Officer, Robert Fried, will present on Wednesday, October 21st at 1:30 p.m. PT. To register for the Niagen Bioscience webcast, pleas

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.